Karyopharm Therapeutics, Inc. (KPTI)
7.85
-0.05
(-0.63%)
USD |
NASDAQ |
Mar 13, 16:00
7.86
+0.01
(+0.13%)
After-Hours: 20:00
Karyopharm Therapeutics Market Cap : 144.00M for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 41.57B |
| Baxter International, Inc. | 8.952B |
| Bruker Corp. | 5.137B |
| Catalyst Pharmaceuticals, Inc. | 2.837B |
| Agios Pharmaceuticals, Inc. | 1.632B |
Market Cap Related Metrics
| PS Ratio | 0.5866 |
| PEG Ratio | -0.0017 |
| Price | 7.85 |
| Earnings Yield | -211.7% |
| PEGY Ratio | -0.0017 |